StockData
Axogen, Inc. logo

Axogen, Inc. (AXGN) stock

AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30142% above fair value
$55.37−0.01 (-0.02%)

Close on Nov 17, 2026Market cap $3.31BP/E –Yield –

Axogen total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Axogen's total debt was $0 at Sep 30, 2026. For fiscal 2025 it was $48.39M, up 1.9% from the year before. Over ten years it grew 7.0% a year on average. The highest annual figure on record is $48.39M in fiscal 2025.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$48.39M+1.9%
FY2024Dec 31, 2024$47.50M+1.9%
FY2023Dec 31, 2023$46.60M+1.9%
FY2022Dec 31, 2022$45.71M+2.0%
FY2021Dec 31, 2021$44.82M+39.9%
FY2020Dec 31, 2020$32.03M+1744.9%
FY2019Dec 31, 2019$1.74M+2655.6%
FY2018Dec 31, 2018$63.00K-99.7%
FY2017Dec 31, 2017$20.55M+1.3%
FY2016Dec 31, 2016$20.29M-17.9%
FY2015Dec 31, 2015$24.70M-1.5%
FY2014Dec 31, 2014$25.09M-1.1%
FY2013Dec 31, 2013$25.36M+17.5%
FY2012Dec 31, 2012$21.58M+346.0%
FY2011Dec 31, 2011$4.84M-31.7%
FY2010Dec 31, 2010$7.08M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$0-100.0%
Q2 FY2026Jun 30, 2026$0-100.0%
Q1 FY2026Mar 31, 2026$0-100.0%
Q4 FY2025Dec 31, 2025$48.39M+1.9%
Q3 FY2025Sep 30, 2025$48.16M+1.9%
Q2 FY2025Jun 30, 2025$47.94M+1.9%
Q1 FY2025Mar 31, 2025$47.72M+1.9%
Q4 FY2024Dec 31, 2024$47.50M+1.9%
Q3 FY2024Sep 30, 2024$47.27M+1.9%
Q2 FY2024Jun 30, 2024$47.05M+1.9%
Q1 FY2024Mar 31, 2024$46.83M+1.9%
Q4 FY2023Dec 31, 2023$46.60M+1.9%
Q3 FY2023Sep 30, 2023$46.38M+2.0%
Q2 FY2023Jun 30, 2023$46.15M+2.0%
Q1 FY2023Mar 31, 2023$45.93M+2.0%
Q4 FY2022Dec 31, 2022$45.71M+2.0%
Q3 FY2022Sep 30, 2022$45.49M-1.6%
Q2 FY2022Jun 30, 2022$45.26M-1.8%
Q1 FY2022Mar 31, 2022$45.04M+40.1%
Q4 FY2021Dec 31, 2021$44.82M+39.9%
Q3 FY2021Sep 30, 2021$46.24M+115.3%
Q2 FY2021Jun 30, 2021$46.08M+2867.2%
Q1 FY2021Mar 31, 2021$32.14M+980.7%
Q4 FY2020Dec 31, 2020$32.03M+1744.9%
Q3 FY2020Sep 30, 2020$21.48M+468.9%
Q2 FY2020Jun 30, 2020$1.55M-63.1%
Q1 FY2020Mar 31, 2020$2.97M-35.1%
Q4 FY2019Dec 31, 2019$1.74M+2655.6%
Q3 FY2019Sep 30, 2019$3.78M+4982.4%
Q2 FY2019Jun 30, 2019$4.21M+4899.5%
Q1 FY2019Mar 31, 2019$4.58M-77.8%
Q4 FY2018Dec 31, 2018$63.00K-99.7%
Q3 FY2018Sep 30, 2018$74.28K-99.6%
Q2 FY2018Jun 30, 2018$84.27K-99.6%
Q1 FY2018Mar 31, 2018$20.60M+1.5%
Q4 FY2017Dec 31, 2017$20.55M+1.3%
Q3 FY2017Sep 30, 2017$20.38M–
Q2 FY2017Jun 30, 2017$20.34M–
Q1 FY2017Mar 31, 2017$20.30M–
Q4 FY2016Dec 31, 2016$20.29M–

More Axogen figures

See a number that looks wrong?